Anti-CCL2 (Carlumab) -McMMAF
Product Specifications
Target
Microtubule Associated, CCR, Antibody-Drug Conjugates (ADCs), Apoptosis
Related Pathways
Microbiology/Virology, Immunology/Inflammation, Cytoskeletal Signaling, GPCR/G Protein, Antibody-drug Conjugate/ADC Related, Apoptosis
Bioactivity
Anti-CCL2 (Carlumab) -McMMAF is an antibody-drug conjugate (ADC) composed of the humanized anti-CCL2 (chemokine ligand 2) antibody Carlumab, linked with the protective group maleimidocaproyl and the tubulin inhibitor MMAF. The cytotoxic molecule and linker in this ADC are McMMAF. Anti-CCL2 (Carlumab) -McMMAF can induce apoptosis and is used in cancer research.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC940034-100 1x 100 µL
Cytokeratin 8/18 (C-51), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC470409-100 1x 100 µL
UPK3A (Uroplakin 3A) (Rabbit PAb), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC400879-100 1x 100 µL
P57 / KIP2 (KP10), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details